BPC-157 / TB-500 / GHK Cu / KPV 10/10/50/10 mg (80mg)

140,00 

CHEMICAL PROPERTIES

Property Specification
Peptide Components GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), KPV (10mg)
Molecular weight BPC-157: ~1419.7 g/mol

TB-500: ~4965 g/mol (synthetic fragment reference)

KPV: ~369.5–419.5 g/mol (depending on form)

GHK-Cu: ~498.2 g/mol

(The molecular weight of the blend depends on the proportions and concentration of each peptide in the mixture.) 

CAS BPC-157: 137525-51-0

TB-500: 885340-08-9 (synthetic fragment reference)

KPV: 10427-79-5

GHK-Cu: 49557-75-7

Chemical formula BPC-157: C₆₂H₉₈N₁₆O₂₂

TB-500: Based on Thymosin β4 reference peptide (C₂₁₂H₃₅₀N₅₆O₇₈S); actual composition may vary

KPV: C₁₂H₂₃N₃O₄

GHK-Cu: C₁₄H₂₄CuN₆O₄

Amino acid sequence BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Pro-Ala-Gly-Asp-Asp-Ala-Glu-Val-Gly

TB-500: derived from Thymosin β4 (synthetic fragment; synthetic fragments may vary)

KPV: Lys-Pro-Val

GHK-Cu: Gly-His-Lys

Solubility All peptides are soluble in aqueous solutions at neutral pH
Purity ≥98% (HPLC), confirmed by analytical testing
Vial Content 80mg Total
Form Lyophilized powder

 

 

1. PRODUCT SUMMARY

This blend is a sophisticated research formulation combining four potent signaling peptides: BPC-157, TB-500, GHK-Cu, and KPV. This combination is specifically designed to evaluate the intersection of rapid tissue repair and immunological regulation. By integrating a potent anti-inflammatory tripeptide (KPV) with established regenerative factors, the blend serves as an advanced platform for studying wound healing kinetics, muscle recovery, and cellular rejuvenation in preclinical assays.

 

2. STORAGE PROTOCOL

Lyophilized State: Maintain at -20°C (-4°F) for maximum stability. Protect from light.

Reconstituted Solution: Store at 2–8°C (36–46°F) post-reconstitution.

Stability Window: Use within 30 days of mixing to ensure experimental accuracy.

3. RESEARCH APPLICATIONS

Advanced Tissue Regeneration: Examining synergistic cellular repair across multiple tissue types.

Immunological Modulation: Studying the role of KPV in balancing immune responses during the recovery phase.

Angiogenesis & Matrix Remodeling: Investigating the formation of new vasculature and collagen deposition.

Anti-Inflammatory Kinetics: Mapping the engagement of pathways responsible for reducing systemic and localized inflammation.

4. REGULATORY DISCLAIMER

NOTICE: This formulation is supplied exclusively for academic and laboratory research and development. It is STRICTLY NOT FOR HUMAN CONSUMPTION, nor is it intended for therapeutic or diagnostic use. Handling must be restricted to qualified scientific professionals in controlled laboratory environments. This product is not designed to diagnose, treat, or prevent any medical condition.

 

5. REFERENCES 

  1. Regenerative and protective actions of the GHK-Cu peptide in human tissue
    https://pubmed.ncbi.nlm.nih.gov/29986520
  2. GHK peptide as a natural modulator of multiple cellular processes
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379
  3. Stimulation of collagen synthesis by GHK-Cu in fibroblast cultures
    https://www.sciencedirect.com/science/article/pii/001457938880509X
  4. The human tripeptide GHK-Cu in prevention of oxidative stress and healing
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3359723
  5. Copper tripeptide effects on wound healing in animal models
    https://pubmed.ncbi.nlm.nih.gov/23744835
  6. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8275860
  7. Pentadecapeptide BPC 157 Enhances Healing and Tendon Repair
    https://pubmed.ncbi.nlm.nih.gov/21030672
  8. Impact of Pentadecapeptide BPC 157 on Muscle Healing
    https://pubmed.ncbi.nlm.nih.gov/20190676
  9. Emerging Use of BPC 157 in Orthopaedic Sports Medicine
    https://pubmed.ncbi.nlm.nih.gov/40756949
  10. Utilizing Developmentally Essential Secreted Peptides Such as Thymosin β4
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050
  11. Thymosin β4 Accelerates Wound Healing
    https://pubmed.ncbi.nlm.nih.gov/10469335
  12. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
    https://www.researchgate.net/publication/5787378_PepT1-Mediated_Tripeptide_KPV_Uptake_Reduces_Intestinal_Inflammation
  13. Are melanocortin peptides future therapeutics for cutaneous wounds and skin ulcers
    https://pubmed.ncbi.nlm.nih.gov/30661264/
  14. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV)
    https://www.sciencedirect.com/science/article/abs/pii/S0022354917301740

Reviews

There are no reviews yet.

Be the first to review “BPC-157 / TB-500 / GHK Cu / KPV 10/10/50/10 mg (80mg)”

Your email address will not be published. Required fields are marked *

Shopping Cart